title: Is deferred use of bevacizumab for glioblastoma associated with prolonged survival?
authors: Department of Neurosurgery, Università Cattolica del Sacro Cuore, Rome, Italy.
authors: Quintino Giorgio
authors: QG
authors: D'Alessandris
authors: Department of Neurosurgery, Università Cattolica del Sacro Cuore, Rome, Italy.
authors: Gabriele
authors: G
authors: Capo
authors: Department of Neurosurgery, Università Cattolica del Sacro Cuore, Rome, Italy.
authors: Roberto
authors: R
authors: Pallini
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy*; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized